Lotus Eye Hospital & Institute (BOM:532998) 3-Year RORE % : -104.58% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:532998 Lotus Eye Hospital & Institute Ltd BOM:532998
67 GF Score
Price ₹115.65
GF Value ₹92.57
Valuation Modestly Overvalued
View Full Analysis

What is Lotus Eye Hospital & Institute 3-Year RORE %?

Lotus Eye Hospital & Institute BOM:532998 -1.28% 67 3-Year RORE % is -104.58 as of Mar. 2026. GuruFocus rates BOM:532998 with a GF Score™ of 67/100 and a GF Value™ of ₹92.57 (Modestly Overvalued). Among 597 Healthcare Providers & Services companies, Lotus Eye Hospital & Institute ranks worse than 92.13% on this metric.

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Lotus Eye Hospital & Institute's 3-Year RORE % for the quarter that ended in Mar. 2026 was -104.58%.

The industry rank for Lotus Eye Hospital & Institute's 3-Year RORE % or its related term are showing as below:

BOM:532998's 3-Year RORE % is ranked worse than
92.13% of 597 companies
in the Healthcare Providers & Services industry
Industry Median: 0.91 vs BOM:532998: -104.58

Lotus Eye Hospital & Institute  (BOM:532998) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Lotus Eye Hospital & Institute 3-Year RORE % Related Terms


Lotus Eye Hospital & Institute 3-Year RORE % Historical Data

* Premium members only.

The historical data trend for Lotus Eye Hospital & Institute's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lotus Eye Hospital & Institute 3-Year RORE % Chart

Lotus Eye Hospital & Institute Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
3-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 42.34 37.85 -1.20 -58.61 -104.58

Lotus Eye Hospital & Institute Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -58.61 -70.82 -65.85 -79.10 -104.58

BOM:532998 vs HCA, THC, DVA: 3-Year RORE % Comparison

For the Medical Care Facilities subindustry, Lotus Eye Hospital & Institute's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lotus Eye Hospital & Institute 3-Year RORE % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Lotus Eye Hospital & Institute's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where Lotus Eye Hospital & Institute's 3-Year RORE % falls into.


BOM:532998
67GF Score
Lotus Eye Hospital & Institute Ltd BOM:532998
3-Year RORE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lotus Eye Hospital & Institute 3-Year RORE % Calculation

Lotus Eye Hospital & Institute's 3-Year RORE % for the quarter that ended in Mar. 2026 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( 0.04-1.41 )/( 1.81-0.5 )
=-1.37/1.31
=-104.58 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2026 and 3-year before.

Frequently Asked Questions Learn more about 3-Year RORE % →
What does a 3-Year RORE % of -104.58 mean?
Lotus Eye Hospital & Institute (BOM:532998) has a 3-Year RORE % of -104.58 as of Mar. 2026. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Lotus Eye Hospital & Institute and its competitors. According to the industry distribution chart, Lotus Eye Hospital & Institute ranks #550 out of 597 companies in the Healthcare Providers & Services industry, placing it in the top 92.1%.
Is Lotus Eye Hospital & Institute's 3-Year RORE % too high?
Lotus Eye Hospital & Institute's current 3-Year RORE % is -104.58. Based on the distribution chart, Lotus Eye Hospital & Institute ranks #550 out of 597 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Lotus Eye Hospital & Institute has a GF Score™ of 67/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Lotus Eye Hospital & Institute's 3-Year RORE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Lotus Eye Hospital & Institute ranks #550 out of 597 companies for 3-Year RORE %. This places Lotus Eye Hospital & Institute in the lower half of its industry. The industry median 3-Year RORE % is 0.91. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Healthcare Providers & Services company?
The median 3-Year RORE % among Healthcare Providers & Services companies is 0.91, based on 597 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Lotus Eye Hospital & Institute and its competitors. For the Healthcare Providers & Services industry, the median 3-Year RORE % is 0.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lotus Eye Hospital & Institute's current 3-Year RORE % is -104.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lotus Eye Hospital & Institute stock overvalued right now?
Based on GuruFocus' analysis, Lotus Eye Hospital & Institute (BOM:532998) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹92.57, compared to a current price of ₹115.65 — trading 24.9% above its estimated fair value. The current 3-Year RORE % is -104.58. Lotus Eye Hospital & Institute's overall GF Score™ is 67/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Lotus Eye Hospital & Institute (BOM:532998), the current 3-Year RORE % is -104.58 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lotus Eye Hospital & Institute (BOM:532998) Overvalued in 2026?

Based on GuruFocus' analysis, Lotus Eye Hospital & Institute stock appears to be overvalued. The current stock price of ₹115.65 is trading 24.9% above its estimated GF Value™ of ₹92.57. GuruFocus considers Lotus Eye Hospital & Institute to be Modestly Overvalued.

Key valuation signals for BOM:532998:

  • 3-Year RORE %: -104.58
  • GF Value™: ₹92.57 vs. price of ₹115.65 (24.9% above fair value)
  • GF Score™: 67/100

No single metric tells the full story. See the BOM:532998 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Lotus Eye Hospital & Institute Business Description

Other Exchanges LOTUSEYE:India
Address SF No. 770/12, Avinashi Road, Civil Aerodrome Post, Coimbatore, TN, IND, 641 014
Lotus Eye Hospital & Institute Ltd is an India-based eye care hospital. It is engaged in providing treatment and care for eye diseases and disorders. It offers treatment services for eye conditions like refractive error, retina and uvea, cornea, glaucoma, pediatric, orbit and oculoplasty, neuro-ophthalmology, and binocular vision. In addition, the company also operates an eye bank for functioning eye donation activities. The company mainly operates in India and generates revenue by providing medical services, pharmacy sales, contact lenses, and optical, of which the majority of the revenue is derived from providing segmmedical services.
67GF Score

Get the complete analysis for BOM:532998

3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹115.65
Price
₹92.57
GF Value